世界の黄斑変性症の治療市場：市場規模・現状・予測

• 英文タイトル：Global Macular Degeneration Treatment Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9N7494
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当資料は、黄斑変性症の治療のグローバル市場について調査・分析したレポートで、種類別（ルセンティス、アイリーア、アバスチン、その他）、用途別（病院、アイクリニック、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・黄斑変性症の治療の世界市場規模
・主要企業別市場シェア
・黄斑変性症の治療の世界市場規模：種類別（ルセンティス、アイリーア、アバスチン、その他）
・黄斑変性症の治療の世界市場規模：用途別（病院、アイクリニック、その他）
・黄斑変性症の治療のアメリカ市場規模（種類別、用途別）
・黄斑変性症の治療のヨーロッパ市場規模（種類別、用途別）
・黄斑変性症の治療の中国市場規模（種類別、用途別）
・黄斑変性症の治療の日本市場規模（種類別、用途別）
・黄斑変性症の治療の東南アジア市場規模（種類別、用途別）
・黄斑変性症の治療のインド市場規模（種類別、用途別）
・黄斑変性症の治療の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・黄斑変性症の治療の世界市場予測（2019年-2025年）
・黄斑変性症の治療の地域別市場予測（2019年-2025年）
...

Macular degeneration, also known as age-related macular degeneration (AMD or ARMD), is a medical condition which may result in blurred or no vision in the center of the visual field. Early on there are often no symptoms. Over time, however, some people experience a gradual worsening of vision that may affect one or both eyes. While it does not result in complete blindness, loss of central vision can make it hard to recognize faces, drive, read, or perform other activities of daily life. Visual hallucinations may also occur but these do not represent a mental illness.In 2018, the global Macular Degeneration Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Macular Degeneration Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Macular Degeneration Treatment development in United States, Europe and China.

The key players covered in this study
Bausch Health Companies
Allergan
Novartis
Pfizer
Bayer
Roche
Sanofi
Santen Pharmaceuticals
Regeneron Pharmaceuticals
Kanghong Pharma

Market segment by Type, the product can be split into
Lucentis
Eylea
Avastin
Others

Market segment by Application, split into
Hospitals
Eye Clinics
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Macular Degeneration Treatment status, future forecast, growth opportunity, key market and key players.
To present the Macular Degeneration Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Macular Degeneration Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Macular Degeneration Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Lucentis
1.4.3 Eylea
1.4.4 Avastin
1.4.5 Others
1.5 Market by Application
1.5.1 Global Macular Degeneration Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Eye Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Macular Degeneration Treatment Market Size
2.2 Macular Degeneration Treatment Growth Trends by Regions
2.2.1 Macular Degeneration Treatment Market Size by Regions (2014-2025)
2.2.2 Macular Degeneration Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Macular Degeneration Treatment Market Size by Manufacturers
3.1.1 Global Macular Degeneration Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Macular Degeneration Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Macular Degeneration Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Macular Degeneration Treatment Key Players Head office and Area Served
3.3 Key Players Macular Degeneration Treatment Product/Solution/Service
3.4 Date of Enter into Macular Degeneration Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Macular Degeneration Treatment Market Size by Type (2014-2019)
4.2 Global Macular Degeneration Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Macular Degeneration Treatment Market Size (2014-2019)
5.2 Macular Degeneration Treatment Key Players in United States
5.3 United States Macular Degeneration Treatment Market Size by Type
5.4 United States Macular Degeneration Treatment Market Size by Application

6 Europe
6.1 Europe Macular Degeneration Treatment Market Size (2014-2019)
6.2 Macular Degeneration Treatment Key Players in Europe
6.3 Europe Macular Degeneration Treatment Market Size by Type
6.4 Europe Macular Degeneration Treatment Market Size by Application

7 China
7.1 China Macular Degeneration Treatment Market Size (2014-2019)
7.2 Macular Degeneration Treatment Key Players in China
7.3 China Macular Degeneration Treatment Market Size by Type
7.4 China Macular Degeneration Treatment Market Size by Application

8 Japan
8.1 Japan Macular Degeneration Treatment Market Size (2014-2019)
8.2 Macular Degeneration Treatment Key Players in Japan
8.3 Japan Macular Degeneration Treatment Market Size by Type
8.4 Japan Macular Degeneration Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Macular Degeneration Treatment Market Size (2014-2019)
9.2 Macular Degeneration Treatment Key Players in Southeast Asia
9.3 Southeast Asia Macular Degeneration Treatment Market Size by Type
9.4 Southeast Asia Macular Degeneration Treatment Market Size by Application

10 India
10.1 India Macular Degeneration Treatment Market Size (2014-2019)
10.2 Macular Degeneration Treatment Key Players in India
10.3 India Macular Degeneration Treatment Market Size by Type
10.4 India Macular Degeneration Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Macular Degeneration Treatment Market Size (2014-2019)
11.2 Macular Degeneration Treatment Key Players in Central & South America
11.3 Central & South America Macular Degeneration Treatment Market Size by Type
11.4 Central & South America Macular Degeneration Treatment Market Size by Application

12 International Players Profiles
12.1 Bausch Health Companies
12.1.1 Bausch Health Companies Company Details
12.1.2 Company Description and Business Overview
12.1.3 Macular Degeneration Treatment Introduction
12.1.4 Bausch Health Companies Revenue in Macular Degeneration Treatment Business (2014-2019)
12.1.5 Bausch Health Companies Recent Development
12.2 Allergan
12.2.1 Allergan Company Details
12.2.2 Company Description and Business Overview
12.2.3 Macular Degeneration Treatment Introduction
12.2.4 Allergan Revenue in Macular Degeneration Treatment Business (2014-2019)
12.2.5 Allergan Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Macular Degeneration Treatment Introduction
12.3.4 Novartis Revenue in Macular Degeneration Treatment Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 Pfizer
12.4.1 Pfizer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Macular Degeneration Treatment Introduction
12.4.4 Pfizer Revenue in Macular Degeneration Treatment Business (2014-2019)
12.4.5 Pfizer Recent Development
12.5 Bayer
12.5.1 Bayer Company Details
12.5.2 Company Description and Business Overview
12.5.3 Macular Degeneration Treatment Introduction
12.5.4 Bayer Revenue in Macular Degeneration Treatment Business (2014-2019)
12.5.5 Bayer Recent Development
12.6 Roche
12.6.1 Roche Company Details
12.6.2 Company Description and Business Overview
12.6.3 Macular Degeneration Treatment Introduction
12.6.4 Roche Revenue in Macular Degeneration Treatment Business (2014-2019)
12.6.5 Roche Recent Development
12.7 Sanofi
12.7.1 Sanofi Company Details
12.7.2 Company Description and Business Overview
12.7.3 Macular Degeneration Treatment Introduction
12.7.4 Sanofi Revenue in Macular Degeneration Treatment Business (2014-2019)
12.7.5 Sanofi Recent Development
12.8 Santen Pharmaceuticals
12.8.1 Santen Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Macular Degeneration Treatment Introduction
12.8.4 Santen Pharmaceuticals Revenue in Macular Degeneration Treatment Business (2014-2019)
12.8.5 Santen Pharmaceuticals Recent Development
12.9 Regeneron Pharmaceuticals
12.9.1 Regeneron Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Macular Degeneration Treatment Introduction
12.9.4 Regeneron Pharmaceuticals Revenue in Macular Degeneration Treatment Business (2014-2019)
12.9.5 Regeneron Pharmaceuticals Recent Development
12.10 Kanghong Pharma
12.10.1 Kanghong Pharma Company Details
12.10.2 Company Description and Business Overview
12.10.3 Macular Degeneration Treatment Introduction
12.10.4 Kanghong Pharma Revenue in Macular Degeneration Treatment Business (2014-2019)
12.10.5 Kanghong Pharma Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Macular Degeneration Treatment Key Market Segments
Table Key Players Macular Degeneration Treatment Covered
Table Global Macular Degeneration Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Macular Degeneration Treatment Market Size Market Share by Type 2014-2025
Figure Lucentis Figures
Table Key Players of Lucentis
Figure Eylea Figures
Table Key Players of Eylea
Figure Avastin Figures
Table Key Players of Avastin
Figure Others Figures
Table Key Players of Others
Table Global Macular Degeneration Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Eye Clinics Case Studies
Figure Others Case Studies
Figure Macular Degeneration Treatment Report Years Considered
Table Global Macular Degeneration Treatment Market Size 2014-2025 (Million US$)
Figure Global Macular Degeneration Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Macular Degeneration Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Macular Degeneration Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Macular Degeneration Treatment Market Share by Regions 2014-2019
Figure Global Macular Degeneration Treatment Market Share by Regions 2014-2019
Figure Global Macular Degeneration Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Macular Degeneration Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Macular Degeneration Treatment Market Share by Manufacturers (2014-2019)
Figure Global Macular Degeneration Treatment Market Share by Manufacturers in 2018
Table Global Macular Degeneration Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Macular Degeneration Treatment Product/Solution/Service
Table Date of Enter into Macular Degeneration Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Macular Degeneration Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Macular Degeneration Treatment Market Size Share by Type (2014-2019)
Figure Global Macular Degeneration Treatment Market Size Market Share by Type (2014-2019)
Table Global Macular Degeneration Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Macular Degeneration Treatment Market Size Share by Application (2014-2019)
Figure Global Macular Degeneration Treatment Market Size Market Share by Application (2014-2019)
Figure Global Macular Degeneration Treatment Revenue Market Share by Application in 2018
Figure United States Macular Degeneration Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Macular Degeneration Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Macular Degeneration Treatment Market Share (2018-2019)
Table United States Macular Degeneration Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Macular Degeneration Treatment Market Share by Type (2014-2019)
Table United States Macular Degeneration Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Macular Degeneration Treatment Market Share by Application (2014-2019)
Figure Europe Macular Degeneration Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Macular Degeneration Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Macular Degeneration Treatment Market Share (2018-2019)
Table Europe Macular Degeneration Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Macular Degeneration Treatment Market Share by Type (2014-2019)
Table Europe Macular Degeneration Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Macular Degeneration Treatment Market Share by Application (2014-2019)
Figure China Macular Degeneration Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Macular Degeneration Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Macular Degeneration Treatment Market Share (2018-2019)
Table China Macular Degeneration Treatment Market Size by Type (2014-20189) (Million US$)
Table China Macular Degeneration Treatment Market Share by Type (2014-2019)
Table China Macular Degeneration Treatment Market Size by Application (2014-2019) (Million US$)
Table China Macular Degeneration Treatment Market Share by Application (2014-2019)
Figure Japan Macular Degeneration Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Macular Degeneration Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Macular Degeneration Treatment Market Share (2018-2019)
Table Japan Macular Degeneration Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Macular Degeneration Treatment Market Share by Type (2014-2019)
Table Japan Macular Degeneration Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Macular Degeneration Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Macular Degeneration Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Macular Degeneration Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Macular Degeneration Treatment Market Share (2018-2019)
Table Southeast Asia Macular Degeneration Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Macular Degeneration Treatment Market Share by Type (2014-2019)
Table Southeast Asia Macular Degeneration Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Macular Degeneration Treatment Market Share by Application (2014-2019)
Figure India Macular Degeneration Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Macular Degeneration Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Macular Degeneration Treatment Market Share (2018-2019)
Table India Macular Degeneration Treatment Market Size by Type (2014-2019) (Million US$)
Table India Macular Degeneration Treatment Market Share by Type (2014-2019)
Table India Macular Degeneration Treatment Market Size by Application (2014-2019) (Million US$)
Table India Macular Degeneration Treatment Market Share by Application (2014-2019)
Figure Central & South America Macular Degeneration Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Macular Degeneration Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Macular Degeneration Treatment Market Share (2018-2019)
Table Central & South America Macular Degeneration Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Macular Degeneration Treatment Market Share by Type (2014-2019)
Table Central & South America Macular Degeneration Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Macular Degeneration Treatment Market Share by Application (2014-2019)
Table Bausch Health Companies Company Details
Table Bausch Health Companies Revenue in Macular Degeneration Treatment Business (2014-2019) (Million US$)
Figure Bausch Health Companies Revenue Growth Rate in Macular Degeneration Treatment Business (2014-2019)
Table Bausch Health Companies Recent Development
Table Allergan Company Details
Table Allergan Revenue in Macular Degeneration Treatment Business (2014-2019)(Million US$)
Figure Allergan Revenue Growth Rate in Macular Degeneration Treatment Business (2014-2019)
Table Allergan Recent Development
Table Novartis Company Details
Table Novartis Revenue in Macular Degeneration Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Macular Degeneration Treatment Business (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Macular Degeneration Treatment Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Macular Degeneration Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Bayer Company Details
Table Bayer Revenue in Macular Degeneration Treatment Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Macular Degeneration Treatment Business (2014-2019)
Table Bayer Recent Development
Table Roche Company Details
Table Roche Revenue in Macular Degeneration Treatment Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Macular Degeneration Treatment Business (2014-2019)
Table Roche Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Macular Degeneration Treatment Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Macular Degeneration Treatment Business (2014-2019)
Table Sanofi Recent Development
Table Santen Pharmaceuticals Company Details
Table Santen Pharmaceuticals Revenue in Macular Degeneration Treatment Business (2014-2019)(Million US$)
Figure Santen Pharmaceuticals Revenue Growth Rate in Macular Degeneration Treatment Business (2014-2019)
Table Santen Pharmaceuticals Recent Development
Table Regeneron Pharmaceuticals Company Details
Table Regeneron Pharmaceuticals Revenue in Macular Degeneration Treatment Business (2014-2019)(Million US$)
Figure Regeneron Pharmaceuticals Revenue Growth Rate in Macular Degeneration Treatment Business (2014-2019)
Table Regeneron Pharmaceuticals Recent Development
Table Kanghong Pharma Company Details
Table Kanghong Pharma Revenue in Macular Degeneration Treatment Business (2014-2019)(Million US$)
Figure Kanghong Pharma Revenue Growth Rate in Macular Degeneration Treatment Business (2014-2019)
Table Kanghong Pharma Recent Development
Table Global Macular Degeneration Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Macular Degeneration Treatment Market Size Share by Regions (2019-2025)
Figure Global Macular Degeneration Treatment Market Size Share by Regions in 2025
Figure United States Macular Degeneration Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Macular Degeneration Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Macular Degeneration Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Macular Degeneration Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Macular Degeneration Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Macular Degeneration Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Macular Degeneration Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Macular Degeneration Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Macular Degeneration Treatment Market Size by Product (2019-2025)
Figure Global Macular Degeneration Treatment Market Size by Product in 2025
Table Global Macular Degeneration Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Macular Degeneration Treatment Market Size by Application (2019-2025)
Figure Global Macular Degeneration Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

世界の黄斑変性症の薬市場：市場規模・現状・予測

Global Macular Degeneration Drugs Market Size, Status and Forecast 2019-2025
QYR9N7493 2019年6月14日 97Pages
当資料は、黄斑変性症の薬のグローバル市場について調査・分析したレポートで、種類別（ルセンティス、アイリーア、アバスチン、スクアラミン、Concecept、その他）、用途別（50〜60歳、60〜70歳、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場...

世界の糖尿病性黄斑浮腫の治療市場：市場規模・現状・予測

Global Diabetic Macular Edema Treatment Market Size, Status and Forecast 2019-2025
QYR9N7092 2019年6月14日 95Pages
当資料は、糖尿病性黄斑浮腫の治療のグローバル市場について調査・分析したレポートで、種類別（レーザー光凝固療法、薬理学療法、ベバシズマブ、ラニビズマブ、トリアムシノロン）、用途別（病院、眼科診療所、研究機関、受託研究機関）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市...

世界の黄斑浮腫治療薬市場：市場規模・現状・予測

Global Macular Edema Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N7495 2019年6月14日 109Pages
当資料は、黄斑浮腫治療薬のグローバル市場について調査・分析したレポートで、種類別（レーザー治療、抗VEGF注射、抗炎症治療、硝子体手術）、用途別（嚢胞状黄斑浮腫（CME）、糖尿病性黄斑浮腫（DME））、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関...

世界の嚢胞状黄斑浮腫市場：市場規模・現状・予測

Global Cystoid Macular Edema Market Size, Status and Forecast 2019-2025
QYR9N7056 2019年6月14日 95Pages
当資料は、嚢胞状黄斑浮腫のグローバル市場について調査・分析したレポートで、種類別（非ステロイド性抗炎症薬、抗血管内皮細胞増殖因子（VEGF）剤、炭酸アンヒドラーゼ阻害剤、ステロイド）、用途別（病院、外来手術センター、その他、）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米...

世界の網膜バイオシミラー市場：市場規模・現状・予測

Global Retinal Biosimilars Market Size, Status and Forecast 2019-2025
QYR9N7963 2019年6月14日 94Pages
当資料は、網膜バイオシミラーのグローバル市場について調査・分析したレポートで、種類別（黄斑変性症の薬、糖尿病性眼疾患治療薬、黄斑パッカー薬、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業...

世界の髄膜炎菌感染症の治療市場：市場規模・現状・予測

Global Meningococcal Infections Treatment Market Size, Status and Forecast 2019-2025
QYR9N7541 2019年6月14日 94Pages
当資料は、髄膜炎菌感染症の治療のグローバル市場について調査・分析したレポートで、種類別（抗生物質、グルココルチコイド、プロテインC濃縮物）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています...

世界の腱炎治療市場：市場規模・現状・予測

Global Tendinitis Treatment Market Size, Status and Forecast 2019-2025
QYR9N8111 2019年6月14日 93Pages
当資料は、腱炎治療のグローバル市場について調査・分析したレポートで、種類別（薬、手術療法、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・腱炎治療...

世界のフォンヴィレブランド病治療市場：市場規模・現状・予測

Global Von Willebrand Disease Treatment Market Size, Status and Forecast 2019-2025
QYR9N8188 2019年6月14日 93Pages
当資料は、フォンヴィレブランド病治療のグローバル市場について調査・分析したレポートで、種類別（ヴェイヴォンディ、フミン酸-P、英数字、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれてい...

世界のディンプル形成術の治療市場：市場規模・現状・予測

Global Dimpleplasty Treatment Market Size, Status and Forecast 2019-2025
QYR9N7109 2019年6月14日 93Pages
当資料は、ディンプル形成術の治療のグローバル市場について調査・分析したレポートで、種類別（光線療法、レーザー治療、その他）、用途別（病院、皮膚科クリニック、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界の精神神経疾患および治療市場：市場規模・現状・予測

Global Neuropsychiatric Disorders And Treatment Market Size, Status and Forecast 2019-2025
QYR9N7660 2019年6月14日 97Pages
当資料は、精神神経疾患および治療のグローバル市場について調査・分析したレポートで、種類別（変性疾患、神経障害、精神病）、用途別（病院、診療所、研究センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
...

世界の黄斑変性症の薬市場：市場規模・現状・予測 Age related macular degeneration (AMD) is a medical condition that results in loss of vision in the central visual field, owing to damage to the retina. This is usually an age-related disorder, which affects adults with the age 50 and above.The North American region is the most lucrative market, owi…
世界の糖尿病性黄斑浮腫の治療市場：市場規模・現状・予測 Diabetic macular edema (DME) is characterized by accumulation of fluid in the macula – a part of retina responsible for vision. Accumulation may cause by leakage of plasma constituents into the surrounding, consequently leading to edema.Increasing prevalence of diabetes in the prime factor driving g…
世界の黄斑浮腫治療薬市場：市場規模・現状・予測 Macula is oval yellowish area surrounding the center of retina in the eye. Macular edema is the state when fluid and protein start accumulating under macula resulting swelling in the eye. Due to this swelling, central vision of eye get distorted. Macular edema is classified into two types namely cys…
世界の嚢胞状黄斑浮腫市場：市場規模・現状・予測 Cystoid macular edema (CME) also known as Irvine Gass Syndrome is a painless disorder affecting the central retina or macula. This condition is characterized by multiple cysts like areas of fluid in the macula causing retinal swelling or edema. CME is the retinal thickening of macula due to disrupti…
世界の網膜バイオシミラー市場：市場規模・現状・予測 In 2018, the global Retinal Biosimilars market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Retinal Biosimilars status, future forecast, growth opportunity, key market and key players. Th…